Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Armodafinil for fatigue in head and neck cancer
NCT01330446Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- May 2011
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of armodafinil in fatigue, sponsored by University of Texas MD Anderson Cancer Center. Started May 2011; status: completed.
02
Drugs
armodafinil
03
Conditions
fatigue
Beyond the preview
Go deeper on NCT01330446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01330446.